Proteomic-based identification of Apg-2 as a therapeutic target for chronic myeloid leukemia

Cell Signal. 2013 Dec;25(12):2604-12. doi: 10.1016/j.cellsig.2013.08.023. Epub 2013 Sep 3.

Abstract

The oncogenic BCR/ABL tyrosine kinase induces constitutive enhanced "spontaneous" DNA damage and unfaithful repair in Philadelphia chromosome positive leukemia cells. Here, we investigated the changes of protein profile in H2O2-induced DNA damage/repair in BaF3-MIGR1 and BaF3-BCR/ABL cells through a proteomic strategy consisting of two-dimensional gel electrophoresis (2-DE) coupled with MALDI-TOF mass spectrometry. In total, 41 spots were differentially expressed and 13 proteins were identified with further MS analysis. Two essential proteins, Proto-oncogene tyrosine-protein kinase ABL1 (c-ABL) and Heat shock 70kDa protein 4 (Apg-2), were confirmed by Western blot and showed consistent changes with proteomic results. Moreover, functional analysis demonstrated that inhibition of Apg-2 not only decreased cell proliferation, but also induced cell apoptosis in BCR/ABL positive cells (BaF3-BCR/ABL, BaF3-BCR/ABL(T315I)). We also proved that Apg-2 inhibition aggravated H2O2 induced damage in BCR/ABL positive cells, and enhanced the sensitivity of BaF3-BCR/ABL(T315I) to STI571. Taken together, the findings in this work provide us with some clues to a better understanding of the molecular mechanisms underlying BCR/ABL in the DNA damage/repair processes and demonstrated that Apg-2 would be a valid target for anti-leukemia drug development.

Keywords: Apg-2; BCR/ABL; Chronic myeloid leukemia; H(2)O(2); Proteomic; shRNA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology
  • Benzamides / pharmacology
  • Cell Cycle
  • Cell Line, Tumor
  • Cell Proliferation
  • Drug Resistance, Neoplasm
  • Gene Expression Regulation, Neoplastic
  • HSP110 Heat-Shock Proteins / genetics*
  • HSP110 Heat-Shock Proteins / metabolism*
  • Hydrogen Peroxide / metabolism
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / metabolism*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
  • Mice
  • Molecular Targeted Therapy
  • Piperazines / pharmacology
  • Proteome / metabolism
  • Proteomics
  • Pyrimidines / pharmacology
  • RNA Interference
  • RNA, Small Interfering / genetics

Substances

  • Antineoplastic Agents
  • Benzamides
  • HSP110 Heat-Shock Proteins
  • Hspa4 protein, mouse
  • Piperazines
  • Proteome
  • Pyrimidines
  • RNA, Small Interfering
  • Imatinib Mesylate
  • Hydrogen Peroxide